Inventor · disambiguated record
Martin Ward
Also filed as: WARD MARTIN · WARD MARTIN RICHARD
6 granted patents·6 pending applications·27 citations·filing 2007–2024
80Inventor score
Files withPDS BIOTECHNOLOGY CORP9THOMAS CHRISTOPHER JOHN ROBERT2BRITISH AMERICAN TOBACCO INVESTMENTS LTD1
Top patents by PatentIndex Score
12 records- 0191US11401306B2HPV16 non HLA-restricted t-cell vaccines, compositions and methods of use thereofPDS BIOTECHNOLOGY CORP·Filed 2017·Granted Aug 2, 2022·9 cites·10 claims
- 0287US11638753B2Lipids as synthetic vectors to enhance antigen processing and presentation ex-vivo in dendritic cell therapyPDS BIOTECHNOLOGY CORP·Filed 2019·Granted May 2, 2023·4 cites·18 claims
- 0386US11612652B2Lipids as synthetic vectors to enhance antigen processing and presentation ex-vivo in dendritic cell therapyPDS BIOTECHNOLOGY CORP·Filed 2016·Granted Mar 28, 2023·4 cites·6 claims
- 0486US8093459B2Modification of plant development and morphologyTHOMAS CHRISTOPHER JOHN ROBERT·Filed 2007·Granted Jan 10, 2012·10 cites·20 claims
- 0577US2025018029A1Methods to alter the tumor microenvironment for effective cancer immunotherapyPDS BIOTECHNOLOGY CORP·Filed 2024·Application pending·0 cites
- 0672US2023285551A1Lipids as synthetic vectors to enhance antigen processing and presentation ex-vivo in dendritic cell therapyPDS BIOTECHNOLOGY CORP·Filed 2023·Application pending·0 cites
- 0769US2023052399A1Methods to alter the tumor microenvironment for effective cancer immunotherapyPDS BIOTECHNOLOGY CORP·Filed 2022·Application pending·0 cites
- 0867US2022332768A1Novel hpv16 non hla-restricted t-cell vaccines, compositions and methods of use thereofPDS BIOTECHNOLOGY CORP·Filed 2022·Application pending·0 cites
- 0963US9481890B2Modification of plant development and morphologyBRITISH AMERICAN TOBACCO INVESTMENTS LTD·Filed 2013·Granted Nov 1, 2016·0 cites·27 claims
- 1055US8575423B2Modification of plant development and morphologyTHOMAS CHRISTOPHER JOHN ROBERT·Filed 2011·Granted Nov 5, 2013·0 cites·28 claims
- 1153US2022160867A1Methods and compositions comprising cationic lipids for immunotherapy by direct tumor injectionPDS BIOTECHNOLOGY CORP·Filed 2021·Application pending·0 cites
- 1249US2018221475A1Methods to alter the tumor microenvironment for effective cancer immunotherapyPDS BIOTECHNOLOGY CORP·Filed 2017·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Martin Ward files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →